Since the activity of SUMOylation regulators is closely associated with global SUMOylation levels, we performed IHC for SUMO1 and SUMO2/3 on FFPE tissue sections from ovarian cancer patients at different stages. Here, SUMO1 is linked to ovarian carcinoma.